Martin Tolstrup at Aarhus University - Research Interests, Publications & Academic Profile

Martin Tolstrup

Professor

Aarhus University

Denmark

Has grant

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do Indian students reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Immunology

100%

Virology

100%

Immune Response

70%

Macrophage Biology

50%

Autoimmunity

40%

Sars-cov-2

40%

Hiv

40%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Recent Grants

Grant: Close

A long-term study of cellular immunity

Open Date: 2021-09-01

Close Date: 2023-09-01

Grant: Close

Development of monoclonal antibodies for COVID-19

Open Date: 2020-05-01

Close Date: 2021-12-01

Grant: Close

CoroNAT: Coronavirus Neutralising antibody therapy

Open Date: 2020-04-01

Close Date: 2021-10-01

Grant: Close

Immunovirology to cure HIV

Open Date: 2019-09-01

Close Date: 2022-03-01

Grant: Close

Viral specific T cells

Open Date: 2019-09-01

Close Date: 2025-04-01

Articles19

Development of antibody levels and subsequent decline in individuals with vaccine induced and hybrid immunity to SARS-CoV-2

Article Link

Year:

2024

Revaccination of patients with systemic lupus erythematosus or rheumatoid arthritis without an initial COVID-19 vaccine response elicits seroconversion in half of the patients

Article Link

Year:

2024

Single-Cell Analysis Reveals That CD47 mRNA Expression Correlates with Immune Cell Activation, Antiviral Isgs, and Cytotoxicity

Article Link

Year:

2024

TLR9 agonism differentially impacts human NK cell-mediated direct killing and antibody-dependent cell-mediated cytotoxicity

Article Link

Year:

2024

Longitudinal evaluation of SARS-CoV-2 T cell immunity over 2 years following vaccination and infection

Article Link

Year:

2024

Development of single-cell transcriptomic atlas of human plasmacytoid dendritic cells from people with HIV-1

Article Link

Year:

2024

Nanobody-mediated complement activation to kill HIV-infected cells

Article Link

Year:

2023

Redirector of Vaccine-induced Effector Responses (RoVER) for specific killing of cellular targets

Article Link

Year:

2023

Development of HIV-Resistant CAR T Cells by CRISPR/Cas-Mediated CAR Integration into the CCR5 Locus

Article Link

Year:

2023

Omicron variant-specific serological imprinting following BA.1 or BA.4/5 bivalent vaccination and previous SARS-CoV-2 infection

Article Link

Year:

2023

A novel SARS-CoV-2 Beta RBD DNA vaccine directly targeted to antigen-presenting cells induces strong humoral and T cell responses

Article Link

Year:

2023

Long-term humoral and cellular immunity after primary SARS-CoV-2 infection

Article Link

Year:

2023

TLR2 and TLR7 mediate distinct immunopathological and antiviral plasmacytoid dendritic cell responses to SARS-CoV-2 infection

Article Link

Year:

2022

Epigenetic landscape in the kick-and-kill therapeutic vaccine BCN02 clinical trial is associated with antiretroviral treatment interruption (ATI) outcome.

Article Link

Year:

2022

Characteristics associated with serological COVID-19 vaccine response and durability in an older population with significant comorbidity: the Danish Nationwide ENFORCE Study.

Article Link

Year:

2022

Effect of 3BNC117 and romidepsin on the HIV-1 reservoir in people taking suppressive antiretroviral therapy (ROADMAP): a randomised, open-label, phase 2A trial

Article Link

Year:

2022

Autoantibodies neutralizing type I IFNs are present in <b>~</b>4% of uninfected individuals over 70 years old and account for <b>~</b>20% of COVID-19 deaths.

Article Link

Year:

2021

Candidate host epigenetic marks predictive for HIV reservoir size, responsiveness to latency reversal, and viral rebound

Article Link

Year:

2021

Effect of age on innate and adaptive immunity in hospitalized covid-19 patients

Article Link

Year:

2021

Collaborators29

Susan Mikkelsen

Aarhus University

DENMARK

Christophe PARIZOT

Sorbonne Université

FRANCE

Rune Hartmann

Professor

Aarhus University

DENMARK

Metz Christine

Professor

Feinstein Institute for Medical Research

UNITED STATES

Clíona Ní Cheallaigh

Associate Professor

Trinity College Dublin

IRELAND

Jacob Thyrsted

Aarhus University

DENMARK

Pierre Vabres

Professor and Chair

Aix-Marseille Université Faculté de Medecine

FRANCE

Mads Kjolby

Aarhus University Hospital

DENMARK

Leif G. Hanitsch

Charité - Universitätsmedizin Berlin

GERMANY

Line Reinert

Aarhus University

DENMARK

Rasmus Bak

Aarhus University

DENMARK

Nick Stub Laursen

Aarhus University

DENMARK

Jörg Hamann

NETHERLANDS

Thomas Benfield

Københavns Universitet

DENMARK

Jesper Gunst

Aarhus University

DENMARK

Ole Søgaard

Professor

Aarhus University

DENMARK

Rikke Olesen

Aarhus University

DENMARK

Nina Breinholt Stærke

Aarhus University

DENMARK

Isik Somuncu Johansen

University of Southern Denmark

DENMARK

Lars Østergaard

Aarhus University

DENMARK

Martijn Beudel

University of Amsterdam

NETHERLANDS

Emma Connolly

Trinity College Dublin

IRELAND

Kristine Raaby Jakobsen

Aarhus University

DENMARK

Martin R. Jakobsen

DENMARK

qiang pan-hammarstrom

Karolinska University Hospital

SWEDEN

Eleftherios Michailidis

Assistant Professor

Emory University

UNITED STATES

Maria C. Puertas

AIDS Research Institute Irsicaixa

SPAIN

Renee M. van der Sluis

Aarhus University

DENMARK

Anne Troldborg

Aarhus University

DENMARK

How do Indian students reach out?

Meet Kite AI